Quantitative

Profiles of Patients with Opioid Use Disorders Presenting a History of Suicidal Ideations and Attempts

Archambault L., Jutras-Aswad D., Touré E.H., Artunduaga A.C., Roy S., Barbeau D., Perreault M., Psychiatric Quarterly, 2022

People who make frequent emergency department visits based on persistence of frequent use in Ontario and Alberta: a retrospective cohort study

Moe J, Wang EY, McGregor MJ, Schull MJ, Dong K, Holroyd BR, Hohl CM, Grafstein E, O’Sullivan F, Trimble J, McGrail KM., CMAJ Open. 2022

Subgroups of people who make frequent emergency department visits in Ontario and Alberta: a retrospective cohort study

Moe J, Wang EY, McGregor MJ, Schull MJ, Dong K, Holroyd BR, Hohl CM, Grafstein E, O’Sullivan F, Trimble J, McGrail KM., CMAJ Open. 2022

Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series

Panagiotoglou D., PLOS ONE, 2022

Cannabis Use and Concern Among Clients Seeking Substance Misuse Treatment: Demographics, Comorbidities, and Service Utilization Patterns Pre-Legalization (2012–2018)

Williamson N, Hathaway J, Jahrig J, Vik S, Rittenbach K., Canadian Journal of Addiction, 2022

Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study

Bahji A, Li Y, Vickers-Smith R, Crystal S, Kerns RD, Gordon KS, Macmadu A, Skanderson M, So-Armah K, Sung ML, Bhondoekhan F, Marshall BDL, Edelman EJ., Int J Environ Res Public Health. 2022

Characterizing people with frequent emergency department visits and substance use: a retrospective cohort study of linked administrative data in Ontario, Alberta, and B.C., Canada

Moe J, Wang YE, Schull MJ, Dong K, McGregor MJ, Hohl CM, Holroyd BR, McGrail KM., BMC Emerg Med. 2022

Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study

Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT., Subst Use Misuse. 2022

Retrospective Cohort Study Examining the Correlates of Reported Lifetime Stimulant Use in Persons Diagnosed With Infectious Syphilis in Alberta, Canada, 2018 to 2019

Raval M, Gratrix J, Plitt S, Niruban J, Smyczek P, Dong K, Singh AE., Sex Transm Dis. 2022

Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids

Juwono S, Milloy MJ, Choi J, Fairbairn N, Nolan S, Socías ME., AIDS. 2022

Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform

Moallef S, Dale L, Homayra F, Zonneveld C, Milloy MJ, Nosyk B, Hayashi K; Vancouver Area Network of Drug Users., J Subst Abuse Treat. 2022

“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada

Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, Brar R, Sutherland C, Le Foll B, Sereda A, Goyer MÈ, Rai N, Bernstein S, Fairbairn N., Canada. Int J Drug Policy. 2022

Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice

Hodgins DC, Budd M, Czukar G, Dubreucq S, Jackson LA, Rush B, Quilty LC, Adams D, Cameron Wild T., Can J Psychiatry. 2022

Crack cocaine use frequency is associated with HIV disease severity independent of antiretroviral therapy exposure: a prospective cohort study

Macmadu A, Reddon H, Marshall BDL, Fairbairn N, Nolan S, Socías ME, Milloy MJ., AIDS Behav. 2022

Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital

Nolan S, Kelian S, Kerr T, Young S, Malmgren I, Ghafari C, Harrison S, Wood E, Lysyshyn M, Holliday E., Alcohol Depend. 2022

Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study

Zolopa C., Brothers T.D., Leclerc P., Mary J.F., Morissette C., Bruneau J., Hyshka E., Martin N.K., Larney S., International Journal of Drug Policy, 2022

Using synthetic controls to estimate the population-level effects of Ontario’s recently implemented overdose prevention sites and consumption and treatment services

Dimitra Panagiotoglou, Jihoon Lim, International Journal of Drug Policy, 2022

The relationship between sexual and gender stigma and suicide attempt and ideation among LGBTQI + populations in Thailand: findings from a national survey

Moallef S, Salway T, Phanuphak N, Kivioja K, Pongruengphant S, Hayashi K., Psychiatry Psychiatr Epidemiol. 2022

Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study

Kim C, Chum A, Nielsen A, Allin S, Penney TL, Rittenbach K, MacMaster FP, O’Campo P., PLoS One. 2022

Shifts in substance use patterns among a cohort of people who use opioids after delisting of OxyContin in BC, Canada: An interrupted time series study

Karamouzian M, Buxton JA, Hategeka C, Nosova E, Hayashi K, Milloy MJ, Kerr T., Int J Drug Policy. 2022

Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment

Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study

Cui Z, Hayashi K, Bach P, Dong H, Milloy MJ, Kerr T., Drug Alcohol Depend. 2022

Injecting drugs alone during an overdose crisis in Vancouver, Canada

Norton A, Hayashi K, Johnson C, Choi J, Milloy MJ, Kerr T., Harm Reduct J. 2022

Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada

Cassie R, Hayashi K, DeBeck K, Milloy MJ, Cui Z, Strike C, West J, Kennedy MC., Harm Reduct J. 2022

Development and pilot evaluation of an educational session to support sparing opioid prescriptions to opioid naïve patients in a Canadian primary care setting

Narayan S, Rizzardo S, Hamilton MA, Cooper I, Maclure M, McCracken RK, Klimas J., Fam Pract. 2022

Sleep as a Mediator Between Cannabis Use and Psychosis Vulnerability: A Longitudinal Cohort Study

Ouellet J., Spinney S., Assaf R., Boers E., Livet A., Potvin S., Conrod P.J., Schizophrenia Bulletin Open, 2022

Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada

Moallef S, Genberg BL, Hayashi K, Mehta SH, Kirk GD, Choi J, DeBeck K, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Milloy MJ., Drug Alcohol Depend. 2022

Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada

Cui Z, Bach P, Ti L, Hayashi K, Morgan J, Milloy MJ, Kerr T., Int J Drug Policy. 2022

Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV

Gorbach PM, Rosen AD, Moore R, Shoptaw S, Mustanski B, Mehta SH, Kirk GD, Baum MK, Milloy MJ, Hayashi K, DeBeck K, Kipke M, Lai S, Siminski S, Javanbakht M., Drug Alcohol Depend. 2022

Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada

Feder KA, Choi J, Schluth CG, Hayashi K, DeBeck K, Milloy MJ, Kirk GD, Mehta SH, Kipke M, Moore RD, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Genberg BL., Drug Alcohol Depend. 2022

Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study

Kennedy MC, Crabtree A, Nolan S, Mok WY, Cui Z, Chong M, Slaunwhite A, Ti L., PLoS Med. 2022

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

Andrews CN, Rehak R, Woo M, Walker I, Ma C, Forbes N, Rittenbach K, Hathaway J, Wilsack L, Liu A, Nasser Y, Sharkey KA.

Factors Associated with Self-Reported Changes in Alcohol Use among Young Adults during the COVID-19 Pandemic: A Comparative Analysis between Canada and France

Coulaud PJ, Airagnes G, McGrath K, Bolduc N, Bertrand K, Jauffret-Roustide M, Knight R., Int J Environ Res Public Health. 2022

Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)

Klein MB, Young J, Ortiz-Paredes D, Wang S, Walmsley S, Wong A, Martel-Laferrière V, Pick N, Conway B, Angel J, Baril JG, Fraser C, Lebouché B, Tan DHS, Sandre R, Trottier S, Peiris H, Jayaraman J, Singer J; CTN 286 Study Investigators., Patient Prefer Adherence, 2022

Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy

Moallef S, DeBeck K, Fairbairn N, Cui Z, Brar R, Wilson D, Johnson C, Milloy MJ, Hayashi K., Addict Sci Clin Pract. 2022

Association of sex work and social-structural factors with non-fatal overdose among women who use drugs in Vancouver, Canada

Harris MT, Goldenberg S, Cui Z, Fairbairn N, Milloy MS, Hayashi K, Samet JH, Walley AY, Nolan S., Int J Drug Policy. 2023

Young Adults’ Mental Health and Unmet Service Needs in the Context of the COVID-19 Pandemic Across Canada and France

Coulaud PJ, Jesson J, Bolduc N, Ferlatte O, Jenkins E, Bertrand K, Salway T, Jauffret-Roustide M, Knight R., Community Ment Health J. 2023

The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs

Lake S, Kerr T, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ., Cannabis Cannabinoid Res. 2023

Documenting cannabis use in primary care: a descriptive cross-sectional study using electronic medical record data in Alberta, Canada

Soos B, Garies S, Cornect-Benoit A, Montgomery L, Sharpe H, Rittenbach K, Manca D, Duerksen K, Forst B, Drummond N., BMC Res Notes., 2024

Increasing trends and incidence of nonfatal overdose among women sex workers who use drugs in British Columbia: The role of criminalization-related barriers to harm reduction

Argento E, Shannon K, Fairbairn N, Moreheart S, Braschel M, Goldenberg S., Drug Alcohol Depend. 2023

The impact of the COVID-19 pandemic on access to supervised consumption programs

Gubskaya E, Kennedy MC, Hayashi K, Cui Z, Milloy MJ, Kerr T., Subst Abuse Treat Prev Policy. 2023

Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17

Larney S., Jones N.R., Hickman M., Nielsen S., Ali R., Degenhardt L., Addiction, 2023

Opportunities and challenges in capturing severe vaping-related injuries among Canadian children and youth

Chadi N., Richmond S.A., Tulloch T., Grant C.N., Venugopal J., Moore-Hepburn C., Preventive Medicine Reports, 2023

Coping and Conformity Motives Mediate the Joint Effects of the Behavioral Inhibition and Approach Systems on Alcohol Problems in Young Adults

Morris V., Keough M.T., Stewart S.H., O’Connor R.M., Substance Use & Misuse, 2023

Coping and conformity motives mediate the joint effects of the behavioral inhibition and approach systems on alcohol problems in young adults

Morris V., Keough M.T., Stewart S.H., O’Connor R.M., Substance Use & Misuse, 2023

Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials

Lim J., Farhat I., Douros A., Panagiotoglou D., PLoS ONE, 2022

Recommendations for reducing the risk of cannabis use-related adverse psychosis outcomes: a public mental health-oriented evidence review

Fischer B, Hall W, Fidalgo TM, Hoch E, Le Foll B, Medina-Mora ME, Reimer J, Tibbo PG, Jutras-Aswad D. , Journal of Dual Diagnosis, 2023

Rating versus ranking in a Delphi survey: a randomized controlled trial

Del Grande C., Kaczorowski J., Trials, 2023

An innovative inpatient protocol for alcohol withdrawal prevention in a 16-year-old adolescent: a case report

Moubayed D, Chadi N., Journal of Medical Case Reports, 2023

Universal hepatitis C virus screening and treatment as part of prenatal care

Marshall AD, Martinello M, Zolopa C, Treloar C, Larney S., Gastroenterol Hepatol. 2023

Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada

Pilarinos A, Bingham B, Kwa Y, Joe R, Grant C, Fast D, Buxton JA, DeBeck K., J Subst Use Addict Treat. 2023

Estimating the prevalence and correlates of pain among people living with HIV who use unregulated drugs in a Canadian setting

Loh J, Buxton J, Kaida A, Voon P, Grant C, Milloy MJ., J Opioid Manag. 2023

Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: A longitudinal analysis

Mitra S, Choi J, van Draanen J, Kerr T, Gilbert M, Hayashi K, Milloy MJ, Johnson C, Richardson L., Int J Drug Policy. 2023

People with opioid use disorders: A taxonomy of treatment entrants to support the development of a profile-based approach to care

Archambault L., Bertrand K., Jutras-Aswad D., Monson E., Touré E.H., Perreault M., Drug and Alcohol Review, 2023

Re-incarceration and associated social, structural and behavioural factors among people who use drugs in an urban Canadian setting

Brooks O, Hayashi K, Cui Z, Milloy MJ, Kerr T, Fairbairn N., Int J Drug Policy. 2023

People with opioid use disorders: A taxonomy of treatment entrants to support the development of a profile-based approach to care

Archambault L., Bertrand K., Jutras-Aswad D., Monson E., Touré E.H., Perreault M., Drug and Alcohol Review, 2023

First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada

Bouck Z, Tricco AC, Rosella LC, Banack HR, Fox MP, Platt RW, Milloy MJ, DeBeck K, Hayashi K, Werb D., Drug Alcohol Depend Rep. 2023

Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial spread to 107 rural and urban Alberta emergency departments

Stone KD, Scott K, Holroyd BR, Lang E, Yee K, Taghizadeh N, Deol J, Dong K, Fanaeian J, Ghosh M, Low K, Ross M, Tanguay R, Faris P, Day N, McLane P., CJEM. 2023

Experiences of violence during the COVID-19 pandemic among people who use drugs in a Canadian setting: a gender-based cross-sectional study

Swaich A, Richardson L, Cui Z, DeBeck K, Milloy MJ, Kerr T, Hayashi K., BMC Public Health. 2023

Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces

Morris H, Bwala H, Wesley J, Hyshka E., Can J Public Health. 2023

Explanatory pathways linking anxiety sensitivity and alcohol (mis)use: A prospective state-trait analysis among emerging adults

Corran C., Hendershot C.S., O’Connor R.M., Psychology of Addictive Behaviors, 2023

Development of a neural network model to predict the presence of fentanyl in community drug samples

Ti L, Grant CJ, Tobias S, Hore DK, Laing R, Marshall BDL., PLoS One. 2023

Experiencing homelessness and progression through the HIV cascade of care among people who use drugs

Reddon H, Fairbairn N, Grant C, Milloy MJ., AIDS. 2023

Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study

van Draanen J, Hamilton J, Morgan J, Maxwell S, Taylor T, Richardson L, Nolan S., Harm Reduct J. 2023

Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis

Eugenia Socias M, Choi JC, Fairbairn N, Johnson C, Wilson D, Debeck K, Brar R, Hayashi K, Int J Drug Policy. 2023

Trends in cocaine and crystal methamphetamine injection over time in a Canadian setting between 2008 and 2018

Bach P, Ti L, Hayashi K, Cui Z, Milloy MJ, Fairbairn N., J Subst Use Addict Treat. 2023

Crystal methamphetamine use and methadone maintenance treatment dissatisfaction: A prospective cohort study in Vancouver, Canada

Cui Z, Hayashi K, Bach P, Milloy MJ, Kerr T., J Subst Use Addict Treat. 2023

Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study

Mok J, Milloy MJ, Grant C, Lake S, DeBeck K, Hayashi K, Kerr T, Socías ME., Cannabis Cannabinoid Res. 2023

Personality-specific pathways from bullying victimization to adolescent alcohol use: a multilevel longitudinal moderated mediation analysis

Laroque FM, Boers E, Afzali MH, Conrod PJ., Development and Psychopathology, 2023

Personality-specific pathways from bullying victimization to adolescent alcohol use: a multilevel longitudinal moderated mediation analysis

Laroque F.M., Boers E., Afzali M.H., Conrod P.J., Development and Psychopathology, 2023

Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002–17

Larney S., Jones N.R., Hickman M., Nielsen S., Ali R., Degenhardt L., Addiction, 2023

Rating versus ranking in a Delphi survey: a randomized controlled trial

Del Grande C., Kaczorowski J., Trials, 2023

Police seizure of drugs without arrest among people who use drugs in Vancouver, Canada, before provincial ‘decriminalization’ of simple possession: a cohort study

Hayashi K, Singh Kelsall T, Shane C, Cui Z; Vancouver Area Network of Drug Users; Milloy MJ, DeBeck K, Kerr T., Harm Reduct J. 2023

Latent polydrug use patterns and the provision of injection initiation assistance among people who inject drugs in three North American settings

Rammohan I, Jain S, Sun S, Marks C, Milloy MJ, Hayashi K, DeBeck K, González-Zúñiga P, Strathdee S, Werb D., Drug Alcohol Rev. 2023

Longitudinal latent polysubstance use patterns among a cohort of people who use opioids in Vancouver, Canada

Karamouzian M, Cui Z, Hayashi K, DeBeck K, Milloy MJ, Buxton JA, Kerr T., Drug Alcohol Rev. 2023

Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis

Reddon H, Lake S, Socias ME, Hayashi K, DeBeck K, Walsh Z, Milloy MJ., Int J Drug Policy. 2023

Cannabis use to manage stimulant cravings among people who use unregulated drugs

Reddon H, Socias ME, DeBeck K, Hayashi K, Walsh Z, Milloy MJ., Addict Behav. 2024

Modeling as Visioning: Exploring the Impact of Criminal Justice Reform on Health of Populations with Substance Use Disorders

Martin N.K., Beletsky L., Linas B.P., Bayoumi A., Pollack H., Larney S., Journal of Urban Health, 2023

What impact did the COVID-19 pandemic have on the variability of fentanyl concentrations in the Vancouver, Canada illicit drug supply? An interrupted time-series analysis

Tobias S, Grant CJ, Laing R, Lysyshyn M, Buxton JA, Tupper KW, Wood E, Ti L, BMJ Public Health, 2023.

Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study

Klaire S, Fairbairn N, Ryan A, Nolan S, McLean M, Bach P., J Addict Med. 2023

Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis

Morris H, Wild TC, Giovannoni M, Haines-Saah R, Koziel J, Schulz P, Bwala H, Kunyk D, Bubela T, Hyshka E., PLoS One. 2023

A Brief Digital Screening and Intervention Tool for Parental and Adolescent Tobacco and Electronic Cigarette Use in Pediatric Medical Care in Canada: Protocol for a Pilot Randomized Controlled Trial

Chadi N., Diamant E., Perez T., Al-Saleh A., Sylvestre M.P., O’Loughlin J., Winickoff J.P., Drouin O., JMIR Research Protocols, 2023

Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials

Bakouni H., Sharafi H., Bahremand A., Drouin S., Ziegler D., Bach P., Le Foll B., Schütz C.G., Tardelli V., Ezard N., Siefried K., Jutras-Aswad D., Drug and Alcohol Dependence, 2023

Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials

Bakouni H., Sharafi H., Bahremand A., Drouin S., Ziegler D., Bach P., Le Foll B., Schütz C.G., Tardelli V., Ezard N., Siefried K., Jutras-Aswad D., Drug and Alcohol Dependence, 2023

Explanatory pathways linking anxiety sensitivity and alcohol (mis)use: A prospective state-trait analysis among emerging adults

Corran C., Hendershot C.S., O’Connor R.M., Psychology of Addictive Behaviors, 2023

Trajectories of opioid consumption as predictors of patient-reported outcomes among individuals attending multidisciplinary pain treatment clinics

Angarita-Fonseca A, Lacasse A, Choinière M, Kaboré JL, Sylvestre MP, Dinkou GDT, Bruneau J, Martel MO, Hovey R, Motulsky A, Rahme E, Pagé MG., Pharmacoepidemiology and Drug Safety, 2024

The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis

Cui Z, Karamouzian M, Law M, Hayashi K, Milloy MJ, Kerr T., Int J Ment Health Addict. 2024

Fentanyl Concentration in Drug Checking Samples and Risk of Overdose Death in Vancouver, Canada

Kennedy MC, Dong H, Tobias S, Buxton JA, Lysyshyn M, Tupper KW, Ti L., Am J Prev Med. 2024

Evaluating the agreement between different substance use recall periods in multiple HIV cohorts

Tang X, Schalet BD, Janulis P, Keruly JC, Moore RD, Milloy MJ, DeBeck K, Hayashi K, Javanbakht M, Kim S, Siminski S, Shoptaw S, Gorbach PM., Drug Alcohol Depend. 2024

Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study

Tobias S, Ferguson M, Palis H, Burmeister C, McDougall J, Liu L, Graham B, Ti L, Buxton JA., Int J Drug Policy. 2024

Child sexual abuse by different classes and types of perpetrator: Prevalence and trends from an Australian national survey

Mathews B., Finkelhor D., Pacella R., Scott J.G., Higgins D.J., Meinck F., Erskine H.E., Thomas H.J., Lawrence D., Malacova E., Haslam D.M., Collin-Vézina D., Child Abuse & Neglect, 2024

Trajectories of opioid consumption as predictors of patient-reported outcomes among individuals attending multidisciplinary pain treatment clinics

Angarita-Fonseca A., Lacasse A., Choinière M., Kaboré J.-L., Sylvestre M.-P., Dinkou G.D.T., Bruneau J., Martel M.O., Hovey R., Motulsky A., Rahme E., Pagé M.G., Pharmacoepidemiology and Drug Safety, 2024

Patterns of change in restrictive measures in residential care: Trauma-informed staff training benefits children and youth who need it the most

Matte-Landry A, Collin-Vézina D., Child Abuse Negl. 2024

Trajectories of opioid consumption as predictors of patient-reported outcomes among individuals attending multidisciplinary pain treatment clinics

Angarita-Fonseca A, Lacasse A, Choinière M, Kaboré JL, Sylvestre MP, Dinkou GDT, Bruneau J, Martel MO, Hovey R, Motulsky A, Rahme E, Pagé MG, Drug Saf. 2024

Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians

MacKinnon N, Lane D, Scheuermeyer F, Kaczorowski J, Dong K, Orkin AM, Daoust R, Moe J, Andolfatto G, Klaiman M, Yan J, Koh JJ, Crowder K, Atkinson P, Savage D, Stempien J, Besserer F, Wale J, Kestler A.,

COVID-19 vaccination among young people who use drugs in Vancouver, Canada

McAdam E, Hayashi K, Barker B, Reddon H, Choi J, Kerr T, DeBeck K., Vaccine. 2024

Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study

Dubois C, Lunghi C, Eurich DT, Dyck JRB, Hyshka E, Hanlon JG, Zongo A., Schizophr Res., 2024

Associations Between Supported Accommodation and Health and Re-offending Outcomes: a Retrospective Data Linkage Study

Gibbs D, Colledge-Frisby S, Farnbach S, Doyle M, Shakeshaft A, Larney S., J Urban Health., 2024

An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study

Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A., Subst Abuse Treat Prev Policy. 2024

Methodology

Publications

Topic

Emergency care

decriminalisation

Harm reduction

Law enforcement/incarceration

Opioid agonist treatment

Prescription monitoring

Psychosocial intervention

Recovery

Sexually transmitted & blood-borne infections

Substance

Alcohol